Natco Pharma Limited has informed the Exchange regarding a press release dated October 31, 2025, titled "NATCO announces launch of its Everolimus tablets, 1 mg, (generic of Zortress®)".
Natco Pharma Limited has informed the Exchange regarding a press release dated October 31, 2025, titled "NATCO announces launch of its Everolimus tablets, 1 mg, (generic of Zortress®)".